Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Clinical trial NCT03471078 · COMPLETED
Trial details
- NCT number
- NCT03471078
- Sponsor
- Sobi, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-12
- Primary completion
- 2020-08-28
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.